In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Felipe Furiati, Senior Director, External Supply Operations at Grünenthal.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Felipe, covering:

Why he stepped away from big pharma to pursue an MBA in the US and transition into top tier management consulting, broadening his global perspective
The pace and intensity of his time at Bain, and how it expanded his problem solving toolkit across industries
The challenges, risks and opportunities involved in acquiring products and integrating supply chains
How he approaches identifying, selecting and managing CDMO partners, and why product characteristics play a critical role
Building and maintaining a CMO and CDMO network, and the key criteria he uses to assess and source new projects
What strong vendor relationships really look like, why not every CDMO can be a strategic partner, and where CMOs can improve

Felipe currently works in External Supply Operations at Grünenthal, a mid-sized pharma organization with a vision of a world free of pain. He is an experienced professional in pharma strategy and operations, with a focus on external supply chain management across both pre launch and commercial products.

Originally from Brazil, Felipe has lived in Ireland and the United States, and is now based in Italy. His experience in the pharmaceutical industry is complemented by time in management consulting, where he gained exposure to a range of sectors including CPG and healthcare services.

Outside of work, Felipe is a mid of the pack endurance triathlete and enjoys spending time outdoors.

Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!